4SC AG
Biopharmaceutical company with no products under development or operational business.
VSC | F
Overview
Corporate Details
- ISIN(s):
- DE000A3E5C40
- LEI:
- 391200QOKN7LGVP0RQ86
- Country:
- Germany
- Address:
- Fraunhoferstr. 22, 82152 Planegg
- Website:
- https://www.4sc.com/
- Sector:
- Manufacturing
Description
4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2016-09-28 07:30 |
4SC sells immunology portfolio to Immunic
|
English | HTML • 12.1 KB | ||
| 2016-09-21 14:33 |
4SC AG: Dr Jason Loveridge appointed new CEO of 4SC
|
English | HTML • 10.9 KB | ||
| 2016-09-21 14:31 |
4SC AG: Dr Jason Loveridge appointed new CEO of 4SC
|
English | HTML • 4.6 KB | ||
| 2016-09-08 07:30 |
Epigenetics: Reprogramming cancer - overcoming drug resistance | 11th 4SC Scien…
|
English | HTML • 15.1 KB | ||
| 2016-08-11 07:30 |
4SC provides operational and financial update for Q2 and 6M 2016
|
English | HTML • 17.9 KB | ||
| 2016-08-11 00:00 |
Half-yearly financial report 2016
|
English | PDF • 267.7 KB | ||
| 2016-08-04 07:30 |
4SC AG: Conference call to be hosted on 11 August 2016 to present the consolida…
|
English | HTML • 8.6 KB | ||
| 2016-07-20 07:30 |
4SC forms international Scientific Expert Panel
|
English | HTML • 15.4 KB | ||
| 2016-06-16 07:30 |
Resminostat boosts cancer immunotherapy
|
English | HTML • 13.2 KB | ||
| 2016-06-02 07:30 |
4SC AG: 4SC at ASCO: 4SC 202 and checkpoint inhibitors - strong partners in can…
|
English | HTML • 14.5 KB | ||
| 2016-05-31 07:30 |
4SC AG: 4SC enters into licensing and development partnership with Link Health …
|
English | HTML • 11.9 KB | ||
| 2016-05-27 15:44 |
4SC AG: 4SC provides headline results from Yakult Honsha's Phase II trial of re…
|
English | HTML • 7.4 KB | ||
| 2016-05-12 07:30 |
4SC reports on key events in Q1 2016
|
English | HTML • 15.0 KB | ||
| 2016-05-12 00:00 |
Q1 statement / Q1 financial report 2016
|
English | PDF • 67.1 KB | ||
| 2016-05-09 15:15 |
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 17.06.2016 in P…
|
German | HTML • 113.9 KB |
Automate Your Workflow. Get a real-time feed of all 4SC AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for 4SC AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for 4SC AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
